Ortho clinical diagnostics reagents and consumables for bdaach, korea

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0224D0008
Awardee
Awarding agency
Task orders
3 $281,880 obligated

Award facts

Opportunity
Combined order value
$281,880 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 37% used
$771,818.90
Maximum order
$154,363.78
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded an indefinite-delivery contract to Quidelortho Sales Company, LLC on October 1, 2024, with a ceiling value of $771,818.90 for ortho clinical diagnostics reagents and consumables supporting BDAACH, Korea. The contract is a single award with no set-aside.

Place of performance includes South Korea and Raritan, New Jersey, with coordination through the Department of Pathology government representative.

The originating procurement, posted as a sources-sought notice on May 1, 2024, sought qualified distributors of reagents and consumables for government-owned Ortho Vision Analyzers. The government required vendors to provide manufacturer authorization documentation as authorized distributors in the Republic of Korea. The contract was structured as firm fixed-price with a base period and four option periods not to exceed 60 months.

The contract runs through September 30, 2025, with option periods extending the potential period to 60 months total.

Three delivery orders have been issued under this IDIQ. The first delivery order, issued October 1, 2024, for $129,912.70 covers ortho clinical diagnostics reagents for the base year with performance in Raritan, New Jersey, and an ultimate completion date of September 30, 2025. A second delivery order issued August 1, 2025, for $4,207.90 for reagents and consumables performed in South Korea, completed September 30, 2025. A third delivery order issued October 1, 2025, for $147,759.58 covers ortho vision reagents performed in South Korea with completion scheduled for September 30, 2026.

Quidelortho Sales Company, LLC is a HUBZone-certified joint venture based in San Diego, California, specializing in medical diagnostic reagents and clinical testing consumables for federal healthcare agencies.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00004 $0
Other Administrative Action P00003 $0
Vendor DUNS or Name Change - Non-Novation P00002 $0
Exercise an Option P00001 · Ortho vision reagents for bdaach, korea. $0
Original award $0

Quick answers

Who was awarded contract W81K0224D0008?

W81K0224D0008 was awarded to Quidelortho Sales Company, LLC by Defense Health Agency (Department of Defense) on October 1, 2024.

How much is contract W81K0224D0008 worth?

Orders under W81K0224D0008 have obligated $281,880. W81K0224D0008's own ceiling is $771,819. A single order can be worth up to $154,364.

How many orders have been placed under contract W81K0224D0008?

3 orders have been placed under W81K0224D0008, the latest on October 1, 2025.

Who can order from contract W81K0224D0008?

W81K0224D0008 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0224D0008 competed?

The extent of competition for W81K0224D0008 was not competed under sap. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV